ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
37 announcements with these filters
Global Health Limited has allotted equity shares under its ESOP/ESPS scheme. This action results in a minor increase in the company's total paid-up share capital.
Global Health Limited has allotted 3,000 equity shares under its employee stock option plan at a premium of Rs. 1,498 per share.
Global Health Limited held its 22nd Annual General Meeting on September 16, 2026. The meeting covered financial statement adoption and shareholder dividend declaration.
Global Health Limited has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 as mandated by SEBI (LODR) regulations.
Global Health Limited has announced its 22nd Annual General Meeting to be held on September 16, 2026, to consider financial statements, dividends, and director re-appointment.
Global Health Limited has submitted its Annual Report for the financial year 2025-26, alongside the notice for its 22nd Annual General Meeting.
Global Health Ltd issued a notice for its 22nd Annual General Meeting, scheduled for September 16, 2026, via video conferencing to transact ordinary and special business.
Global Health (Medanta) delivered Q1 FY27 revenue growth of 26% YoY to INR 13,262 million, driven by robust patient volumes and scaling of the Noida facility.
Global Health (Medanta) delivered strong 26% revenue growth, fueled by higher patient volumes and a rapid turnaround in the new Noida facility.
Global Health (Medanta) reported 26.2% YoY revenue growth in Q1 FY27, driven by strong patient volumes and narrowing losses at the Noida facility.
Global Health reported Q1 FY2027 revenue of ₹1,326.2 Crore, up 26.2% YoY. The company added 72 beds during the quarter and plans a 650-bed Guwahati expansion.
Global Health Ltd will add 650 beds to its new Guwahati hospital project, requiring an investment of ₹970 Crore over the next 3-4 years.
Global Health Limited has appointed Mr. Pradeep Kumar Singh as the company's new Chief Digital Officer, effective July 30, 2026.
Global Health Ltd reported revenue from operations of ₹1,304 Cr (+26.5% YoY) and net profit of ₹157.3 Cr (-1.1% YoY) for Q1 FY27.
Global Health Ltd granted 20,000 ESOPs to one employee under the GHL LTIP 2024. The options have an exercise price of ₹1,147 each.
Global Health Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The company also disclosed the allotment of 4,000 equity shares.
Global Health Ltd has scheduled a board meeting for July 30, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Global Health allotted 4,000 equity shares to its ESOP Trust. The shares were issued at a premium of Rs.1,287 per share.
Global Health Limited received a government LOI to establish a 150‑seat medical college in Gurugram. This expands its education footprint, signalling diversification and long‑term growth.
Global Health Limited filed its Annual Secretarial Compliance Report for the financial year 2025-26. The report by MAKS & CO. confirms general regulatory compliance with minor timing observations.
Global Health Limited allotted 15,900 equity shares under its ESOP scheme. This expansion of paid-up capital reflects employee benefit exercise and routine equity dilution.
Global Health Limited allotted 15,900 equity shares worth ₹1.97 Crore under its employee stock option plan. The allotment increases the company's total paid-up share capital.
Global Health Limited reported FY26 total income growth of 20% to ₹45,089 million with consolidated PAT up 15.1% to ₹5,541 million. Growth was driven by patient volume increases and scaling of developing hospitals.
Medanta delivered a robust FY26 with 20% revenue growth, driven by rapid ramp-up in Noida and maturity in Lucknow/Patna. Management is balancing high-intensity expansion with maintained 24-25% EBITDA margins.
Global Health (Medanta) reported strong FY26 performance with 20% revenue growth and 15% PAT growth. Expansion continues with Noida facility now operational and new projects in Varanasi and Indore.
Global Health Limited reported a FY26 total income of ₹4508.90 Crore, reflecting 19.6% year-on-year growth. The company successfully operationalized its Noida facility and added 623 beds.
Global Health Limited recommended a final dividend of Rs. 0.50 per share for FY 2025-26. The record date will be announced closer to the AGM.
Global Health Limited appointed Kedar Ashok Apte as CMGO and Jagdeep Singh as General Counsel. They replace outgoing General Counsel Richa Singh, strengthening the senior leadership team.
Global Health Ltd reported revenue from operations of ₹1,159 Cr (+24.4% YoY) and net profit of ₹141.7 Cr (+39.7% YoY) for Q4 FY26.
Global Health Limited approved audited FY26 results and recommended a Rs. 0.50 per share final dividend. New leadership appointments were also confirmed to drive growth.